Fate Therapeutics Știri Eulerpool

Fate Therapeutics Eulerpool News

Fate Therapeutics Știri Acțiune

Fate Therapeutics este urmărit de numeroși jurnaliști și investitori din întreaga lume. Cele mai recente Fate Therapeutics știri le adunăm aici.

• 16 mai ·

  Benzinga
  Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
• 16 mai ·

  TipRanks
  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Acumen Pharmaceuticals (ABOS) and DENTSPLY SIRONA (XRAY)
• 16 mai ·

  Thefly.com
  Fate Therapeutics price target lowered by $2 at H.C. Wainwright, here's why
• 15 mai ·

  TipRanks
  Stifel Nicolaus Sticks to Their Hold Rating for Fate Therapeutics (FATE)
• 14 mai ·

  TipRanks
  Hold Rating on Fate Therapeutics Amid Pending Clinical Data and Strategic Pipeline Focus
• 14 mai ·

  TipRanks
  Fate Therapeutics: A Promising Contender in Autoimmune Disease Cell Therapy with Innovative FT819 and FT522 Trials
• 13 mai ·

  Yahoo
  Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
• 13 mai ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Fate Therapeutics (FATE) and Instil Bio (TIL)
• 11 mai ·

  SeekingAlpha
  Fate Therapeutics, Inc. (FATE) Q1 2024 Earnings Call Transcript
• 11 mai ·

  Yahoo
  Fate Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line